| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.84▲ | 0.83▲ | 0.81▲ | 0.78▲ | 0.83▲ |
| MA10 | 0.83▲ | 0.81▲ | 0.79▲ | 0.77▲ | 0.89▼ |
| MA20 | 0.81▲ | 0.78▲ | 0.76▲ | 0.83▲ | 1.02▼ |
| MA50 | 0.77▲ | 0.76▲ | 0.76▲ | 0.91▼ | 1.24▼ |
| MA100 | 0.76▲ | 0.76▲ | 0.81▲ | 1.04▼ | 2.39▼ |
| MA200 | 0.76▲ | 0.85▲ | 0.88▼ | 1.19▼ | 4.16▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | 0.008▲ | 0.011▲ | 0.006▲ | -0.003▼ |
| RSI | 72.457▲ | 74.683▲ | 71.609▲ | 50.463▲ | 36.635▼ |
| STOCH | 88.740▲ | 91.593▲ | 89.455▲ | 43.221 | 11.909▼ |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -41.300 | -75.601▼ |
| CCI | 135.515▲ | 137.574▲ | 187.281▲ | 73.731 | -110.855▼ |
|
Tuesday, December 02, 2025 05:47 AM
PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 03/12/25 | 0.76 | 0.8596 | 0.7537 | 0.8511 | 502,504 |
| 02/12/25 | 0.80 | 0.8082 | 0.7201 | 0.7676 | 1,115,360 |
| 01/12/25 | 0.77 | 0.7757 | 0.703 | 0.7177 | 485,275 |
| 28/11/25 | 0.802 | 0.815 | 0.7664 | 0.771 | 355,750 |
| 26/11/25 | 0.756 | 0.8133 | 0.7446 | 0.8133 | 580,931 |
| 25/11/25 | 0.7524 | 0.7601 | 0.7257 | 0.7456 | 235,401 |
| 24/11/25 | 0.7481 | 0.7852 | 0.7311 | 0.7571 | 274,871 |
| 21/11/25 | 0.7474 | 0.79 | 0.7406 | 0.7554 | 423,056 |
| 20/11/25 | 0.7881 | 0.8237 | 0.7385 | 0.7561 | 646,235 |
| 19/11/25 | 0.7853 | 0.7895 | 0.7293 | 0.75 | 503,808 |
|
|
||||
|
|
||||
|
|